Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Gut microbiome health plays an increasingly recognised role in GLP-1 production
Studies have shown they are equally effective for weight loss and managing blood sugar levels in diabetes as injections
Clinical trials tell the story clearly: Semaglutide (Wegovy) produces average weight loss of 15 to 16 percent of body weight over 68 weeks Tirzepatide (Zepbound) produces average weight loss of 20 to 22.5 percent of body weight, with some participants losing even more Retatrutide , a triple receptor agonist still in clinical trials, has shown weight loss approaching 24 percent in some study arms Tranont Activate, based on the Metabolaid studies of its key ingredients, is associated with roughly 3 extra pounds of weight loss over 8 weeks compared to placebo
10mg 2 vials, ready for dispatch
